| Jewish Hospital & St Mary's Healthcare | |
| 200 Abraham Flexner Way, Louisville, Kentucky 40202 | |
| (502) 587-4011 | |
| Name | Jewish Hospital & St Mary's Healthcare |
|---|---|
| Type | Acute Care Hospital |
| Location | 200 Abraham Flexner Way, Louisville, Kentucky |
| Ownership | Voluntary non-profit - Private |
| Emergency Services | Yes |
| Medicare ID (CCN) | 180040 |
| NPI Number | 1063667012 |
| Organization Name | JEWISH HOSPITAL & ST. MARY'S HEALTHCARE, INC. |
| Doing Business As | FRAZIER REHAB INSTITUTE BRAIN INJURY |
| Address | 220 Abraham Flexner Way, Louisville, KY 40202 |
| Hospital Type | Rehabilitation Hospital |
| Phone Number | 502-582-7484 |
News Archive
Research funded by the National Institutes of Health suggests that changes in a small region of chromosome 6 are risk factors for peanut allergy in U.S. children of European descent. The genetic risk area is located among two tightly linked genes that regulate the presentation of allergens and microbial products to the immune system. This study is the first to use a genome-wide screening approach in patients with well-defined food allergy to identify risks for peanut allergy.
The George Washington School of Public Health and Health Services has partnered with the Grassroot Project, an organization of NCAA Division I varsity athletes using the universal language of sports to engage youth in educational outreach about HIV/AIDS. GW researchers are working with the Grassroot Project to develop and implement a sustainable monitoring and evaluation plan.
New research published in The Lancet has shown that a drug, currently used in the treatment of Type II diabetes, can be effective in clearing fatty liver disease from some patients.
There is more to fighting infection than just clearing the body of pathogens. As important as resisting infection, is limiting damage to the host's tissue caused, very frequently, by toxins produced by pathogens or by components of the host immune response that clears those pathogens.
InVivo Therapeutics Corporation a company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced the successful completion of a reverse merger with InVivo Therapeutics Holdings Corp.
› Verified 9 days ago
| NPI Number | 1073678330 |
| Organization Name | JEWISH HOSPITAL & ST. MARY'S HEALTHCARE, INC. |
| Doing Business As | JEWISH HOSPITAL |
| Address | 200 Abraham Flexner Way, Louisville, KY 40202 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 502-587-4011 |
News Archive
Research funded by the National Institutes of Health suggests that changes in a small region of chromosome 6 are risk factors for peanut allergy in U.S. children of European descent. The genetic risk area is located among two tightly linked genes that regulate the presentation of allergens and microbial products to the immune system. This study is the first to use a genome-wide screening approach in patients with well-defined food allergy to identify risks for peanut allergy.
The George Washington School of Public Health and Health Services has partnered with the Grassroot Project, an organization of NCAA Division I varsity athletes using the universal language of sports to engage youth in educational outreach about HIV/AIDS. GW researchers are working with the Grassroot Project to develop and implement a sustainable monitoring and evaluation plan.
New research published in The Lancet has shown that a drug, currently used in the treatment of Type II diabetes, can be effective in clearing fatty liver disease from some patients.
There is more to fighting infection than just clearing the body of pathogens. As important as resisting infection, is limiting damage to the host's tissue caused, very frequently, by toxins produced by pathogens or by components of the host immune response that clears those pathogens.
InVivo Therapeutics Corporation a company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced the successful completion of a reverse merger with InVivo Therapeutics Holdings Corp.
› Verified 9 days ago
| NPI Number | 1124237375 |
| Organization Name | JEWISH HOSPITAL & ST. MARY'S HEALTHCARE, INC. |
| Doing Business As | OUR LADY OF PEACE EPSDT |
| Address | 2020 Newburg Rd, Louisville, KY 40205 |
| Hospital Type | Psychiatric Hospital |
| Phone Number | 502-451-3330 |
News Archive
Research funded by the National Institutes of Health suggests that changes in a small region of chromosome 6 are risk factors for peanut allergy in U.S. children of European descent. The genetic risk area is located among two tightly linked genes that regulate the presentation of allergens and microbial products to the immune system. This study is the first to use a genome-wide screening approach in patients with well-defined food allergy to identify risks for peanut allergy.
The George Washington School of Public Health and Health Services has partnered with the Grassroot Project, an organization of NCAA Division I varsity athletes using the universal language of sports to engage youth in educational outreach about HIV/AIDS. GW researchers are working with the Grassroot Project to develop and implement a sustainable monitoring and evaluation plan.
New research published in The Lancet has shown that a drug, currently used in the treatment of Type II diabetes, can be effective in clearing fatty liver disease from some patients.
There is more to fighting infection than just clearing the body of pathogens. As important as resisting infection, is limiting damage to the host's tissue caused, very frequently, by toxins produced by pathogens or by components of the host immune response that clears those pathogens.
InVivo Therapeutics Corporation a company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced the successful completion of a reverse merger with InVivo Therapeutics Holdings Corp.
› Verified 9 days ago
| NPI Number | 1417167131 |
| Organization Name | CARITAS PEACE CENTER |
| Address | 2020 Newburg Rd, Louisville, KY 40205 |
| Hospital Type | Psychiatric Hospital |
| Phone Number | 502-451-3330 |
News Archive
Research funded by the National Institutes of Health suggests that changes in a small region of chromosome 6 are risk factors for peanut allergy in U.S. children of European descent. The genetic risk area is located among two tightly linked genes that regulate the presentation of allergens and microbial products to the immune system. This study is the first to use a genome-wide screening approach in patients with well-defined food allergy to identify risks for peanut allergy.
The George Washington School of Public Health and Health Services has partnered with the Grassroot Project, an organization of NCAA Division I varsity athletes using the universal language of sports to engage youth in educational outreach about HIV/AIDS. GW researchers are working with the Grassroot Project to develop and implement a sustainable monitoring and evaluation plan.
New research published in The Lancet has shown that a drug, currently used in the treatment of Type II diabetes, can be effective in clearing fatty liver disease from some patients.
There is more to fighting infection than just clearing the body of pathogens. As important as resisting infection, is limiting damage to the host's tissue caused, very frequently, by toxins produced by pathogens or by components of the host immune response that clears those pathogens.
InVivo Therapeutics Corporation a company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced the successful completion of a reverse merger with InVivo Therapeutics Holdings Corp.
› Verified 9 days ago
| NPI Number | 1588601991 |
| Organization Name | JEWISH HOSPITAL & ST. MARY'S HEALTHCARE, INC. |
| Doing Business As | STS. MARY & ELIZABETH HOSPITAL |
| Address | 1850 Bluegrass Ave, Louisville, KY 40215 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 502-361-6000 |
News Archive
Research funded by the National Institutes of Health suggests that changes in a small region of chromosome 6 are risk factors for peanut allergy in U.S. children of European descent. The genetic risk area is located among two tightly linked genes that regulate the presentation of allergens and microbial products to the immune system. This study is the first to use a genome-wide screening approach in patients with well-defined food allergy to identify risks for peanut allergy.
The George Washington School of Public Health and Health Services has partnered with the Grassroot Project, an organization of NCAA Division I varsity athletes using the universal language of sports to engage youth in educational outreach about HIV/AIDS. GW researchers are working with the Grassroot Project to develop and implement a sustainable monitoring and evaluation plan.
New research published in The Lancet has shown that a drug, currently used in the treatment of Type II diabetes, can be effective in clearing fatty liver disease from some patients.
There is more to fighting infection than just clearing the body of pathogens. As important as resisting infection, is limiting damage to the host's tissue caused, very frequently, by toxins produced by pathogens or by components of the host immune response that clears those pathogens.
InVivo Therapeutics Corporation a company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced the successful completion of a reverse merger with InVivo Therapeutics Holdings Corp.
› Verified 9 days ago
| NPI Number | 1629433693 |
| Organization Name | JEWISH HOSPITAL AND ST. MARY'S HEALTHCARE, INC. |
| Doing Business As | MEDICAL CENTER JEWISH EAST |
| Address | 3290 Dutchmans Lane, Louisville, KY 40207 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 502-259-6000 |
News Archive
Research funded by the National Institutes of Health suggests that changes in a small region of chromosome 6 are risk factors for peanut allergy in U.S. children of European descent. The genetic risk area is located among two tightly linked genes that regulate the presentation of allergens and microbial products to the immune system. This study is the first to use a genome-wide screening approach in patients with well-defined food allergy to identify risks for peanut allergy.
The George Washington School of Public Health and Health Services has partnered with the Grassroot Project, an organization of NCAA Division I varsity athletes using the universal language of sports to engage youth in educational outreach about HIV/AIDS. GW researchers are working with the Grassroot Project to develop and implement a sustainable monitoring and evaluation plan.
New research published in The Lancet has shown that a drug, currently used in the treatment of Type II diabetes, can be effective in clearing fatty liver disease from some patients.
There is more to fighting infection than just clearing the body of pathogens. As important as resisting infection, is limiting damage to the host's tissue caused, very frequently, by toxins produced by pathogens or by components of the host immune response that clears those pathogens.
InVivo Therapeutics Corporation a company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced the successful completion of a reverse merger with InVivo Therapeutics Holdings Corp.
› Verified 9 days ago
| NPI Number | 1912366238 |
| Organization Name | JEWISH HOSPITAL & ST. MARY'S HEALTHCARE, INC. |
| Doing Business As | JEWISH HOSPITAL MEDICAL CENTER NORTHEAST |
| Address | 2401 Terra Crossing Blvd, Louisville, KY 40245 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 502-210-4200 |
News Archive
Research funded by the National Institutes of Health suggests that changes in a small region of chromosome 6 are risk factors for peanut allergy in U.S. children of European descent. The genetic risk area is located among two tightly linked genes that regulate the presentation of allergens and microbial products to the immune system. This study is the first to use a genome-wide screening approach in patients with well-defined food allergy to identify risks for peanut allergy.
The George Washington School of Public Health and Health Services has partnered with the Grassroot Project, an organization of NCAA Division I varsity athletes using the universal language of sports to engage youth in educational outreach about HIV/AIDS. GW researchers are working with the Grassroot Project to develop and implement a sustainable monitoring and evaluation plan.
New research published in The Lancet has shown that a drug, currently used in the treatment of Type II diabetes, can be effective in clearing fatty liver disease from some patients.
There is more to fighting infection than just clearing the body of pathogens. As important as resisting infection, is limiting damage to the host's tissue caused, very frequently, by toxins produced by pathogens or by components of the host immune response that clears those pathogens.
InVivo Therapeutics Corporation a company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced the successful completion of a reverse merger with InVivo Therapeutics Holdings Corp.
› Verified 9 days ago
| NPI Number | 1922467240 |
| Organization Name | JEWISH HOSPITAL AND ST. MARY'S HEALTHCARE, INC. |
| Doing Business As | JEWISH HOSPITAL MEDICAL CENTER SOUTHWEST |
| Address | 9700 Stonestreet Rd, Louisville, KY 40272 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 502-995-2400 |
News Archive
Research funded by the National Institutes of Health suggests that changes in a small region of chromosome 6 are risk factors for peanut allergy in U.S. children of European descent. The genetic risk area is located among two tightly linked genes that regulate the presentation of allergens and microbial products to the immune system. This study is the first to use a genome-wide screening approach in patients with well-defined food allergy to identify risks for peanut allergy.
The George Washington School of Public Health and Health Services has partnered with the Grassroot Project, an organization of NCAA Division I varsity athletes using the universal language of sports to engage youth in educational outreach about HIV/AIDS. GW researchers are working with the Grassroot Project to develop and implement a sustainable monitoring and evaluation plan.
New research published in The Lancet has shown that a drug, currently used in the treatment of Type II diabetes, can be effective in clearing fatty liver disease from some patients.
There is more to fighting infection than just clearing the body of pathogens. As important as resisting infection, is limiting damage to the host's tissue caused, very frequently, by toxins produced by pathogens or by components of the host immune response that clears those pathogens.
InVivo Therapeutics Corporation a company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced the successful completion of a reverse merger with InVivo Therapeutics Holdings Corp.
› Verified 9 days ago
| NPI Number | 1972688471 |
| Organization Name | KINDRED HOSPITALS LIMITED PARTNERSHIP |
| Doing Business As | KINDRED HOSPITAL - LOUISVILLE AT JEWISH HOSPITAL |
| Address | 200 Abraham Flexner Way, 2nd Fl Frazier Inst., Louisville, KY 40202 |
| Hospital Type | Long Term Care Hospital |
| Phone Number | 502-587-3999 |
News Archive
Research funded by the National Institutes of Health suggests that changes in a small region of chromosome 6 are risk factors for peanut allergy in U.S. children of European descent. The genetic risk area is located among two tightly linked genes that regulate the presentation of allergens and microbial products to the immune system. This study is the first to use a genome-wide screening approach in patients with well-defined food allergy to identify risks for peanut allergy.
The George Washington School of Public Health and Health Services has partnered with the Grassroot Project, an organization of NCAA Division I varsity athletes using the universal language of sports to engage youth in educational outreach about HIV/AIDS. GW researchers are working with the Grassroot Project to develop and implement a sustainable monitoring and evaluation plan.
New research published in The Lancet has shown that a drug, currently used in the treatment of Type II diabetes, can be effective in clearing fatty liver disease from some patients.
There is more to fighting infection than just clearing the body of pathogens. As important as resisting infection, is limiting damage to the host's tissue caused, very frequently, by toxins produced by pathogens or by components of the host immune response that clears those pathogens.
InVivo Therapeutics Corporation a company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced the successful completion of a reverse merger with InVivo Therapeutics Holdings Corp.
› Verified 9 days ago
| Able to receive lab results electronically | Yes |
| Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
Research funded by the National Institutes of Health suggests that changes in a small region of chromosome 6 are risk factors for peanut allergy in U.S. children of European descent. The genetic risk area is located among two tightly linked genes that regulate the presentation of allergens and microbial products to the immune system. This study is the first to use a genome-wide screening approach in patients with well-defined food allergy to identify risks for peanut allergy.
The George Washington School of Public Health and Health Services has partnered with the Grassroot Project, an organization of NCAA Division I varsity athletes using the universal language of sports to engage youth in educational outreach about HIV/AIDS. GW researchers are working with the Grassroot Project to develop and implement a sustainable monitoring and evaluation plan.
New research published in The Lancet has shown that a drug, currently used in the treatment of Type II diabetes, can be effective in clearing fatty liver disease from some patients.
There is more to fighting infection than just clearing the body of pathogens. As important as resisting infection, is limiting damage to the host's tissue caused, very frequently, by toxins produced by pathogens or by components of the host immune response that clears those pathogens.
InVivo Therapeutics Corporation a company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced the successful completion of a reverse merger with InVivo Therapeutics Holdings Corp.
› Verified 9 days ago
Jewish Hospital & St Mary's Healthcare Acute Care Hospital Location: 200 Abraham Flexner Way, Louisville, Kentucky 40202 Phone: (502) 587-4011 | |
Norton Hospitals, Inc Acute Care Hospital Location: 200 East Chestnut Street, Louisville, Kentucky 40202 Phone: (502) 629-8000 | |
Baptist Health Louisville Acute Care Hospital Location: 4000 Kresge Way, Louisville, Kentucky 40207 Phone: (502) 897-8100 | |
University Of Louisville Hospital Acute Care Hospital Location: 530 South Jackson Street, Louisville, Kentucky 40202 Phone: (502) 562-3000 | |
The Brook Hospital - Dupont Psychiatric Hospital Location: 1405 Browns Lane, Louisville, Kentucky 40207 Phone: (502) 896-0495 | |
The Brook Hospital - Kmi Psychiatric Hospital Location: 8521 Lagrange Road, Louisville, Kentucky 40242 Phone: (502) 426-6380 |